Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Ramachandran MuraliVP of Research and Development | Kairos PharmaKAPA | Open-market buy | 24/11/25 | 24/11/25 | 200 sh | $1.59 | $318 | +0.2% |
Kairos PharmaKAPA | Open-market buy | 24/11/22 | 24/11/25 | 2,500 sh | $1.50 | $3,750 | +4.3% | |
John S. YuCEO and Chairman | Kairos PharmaKAPA | Open-market buy | 24/11/20 | 24/11/21 | 4,000 sh | $1.44 | $5,760 | +0.1% |